Tag : Azafaros

Healthcare Quality, Patient Safety & Policy

Azafaros Publishes Preclinical Data of Nizubaglustat in GM2

Business Wire
by Business Wire069
Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept...
Clinical Research, Pharma & Healthcare Financing

Azafaros to Present Nizubaglustat Research at WORLDSymposium 2026

Business Wire
by Business Wire070
Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that its...
Workforce Development & Leadership

Azafaros Strengthens Board with Biotech Entrepreneur Appointment

Business Wire
by Business Wire082
Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced the appointment...